Adjuvant treatment of in-transit melanoma: narrowing the knowledge gap left by clinical trials

Author(s):
Meza, M.M. de; Blokx, W.A.M.; Bonenkamp, H.J.; Blank, C.U.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Boers-Sonderen, M.J.; Groot, J.W.B. de; Haanen, J.B.; Hospers, G.A.P.; Kapiteijn, E.W.; Not, O.J. van; Piersma, D.; Rijn, R.S. van; Boer, M.A.S.D.; Veldt, A.A.M. van der; Vreugdenhil, G.; Eertwegh, A.J.M. van den; Suijkerbuijk, K.P.M.; Wouters, M.W.J.M.
Published
2023
Publication type
Article / Letter to editor
adjuvant treatmentmelanomacheckpoint inhibition therapyimmunotherapyin-transit melanoma
Date issued
2023-03-08
Language
English
Is part of
International Journal of Cancer (2023), Vol. 153, no. 2, p. 389-398
hdl
1887/3720757
doi
10.1002/ijc.34485